Effects of Ketoconazole on the Intestinal Metabolism, Transport and Oral Bioavailability of K02, a Novel Vinylsulfone Peptidomimetic Cysteine Protease Inhibitor and a P450 3A, P-Glycoprotein Dual Substrate, in Male Sprague-Dawley Rats

This publication has 28 references indexed in Scilit:

• Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes: Major role of CYP3A
  Biochemical Pharmacology, 1997
• Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*
  Clinical Pharmacology & Therapeutics, 1996
• Substrates of human hepatic cytochrome P450 3A4
  Toxicology, 1995
• The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design
  Parasitology Today, 1995
• Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
  Molecular Carcinogenesis, 1995
• The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*
  Clinical Pharmacology & Therapeutics, 1995
• The Crystal Structure of Cruzain: A Therapeutic Target for Chagas' Disease
  Journal of Molecular Biology, 1995
• Selective Inhibitors of Cytochromes P450
  Toxicology and Applied Pharmacology, 1994
• Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia
  Gastroenterology, 1992
• Effect of cannabidiol on cytochrome P-450 isozymes
  Biochemical Pharmacology, 1989